Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 287 for heart disease

Edit search filters
  1. Safety And Efficacy Of ANX-042 In Human Cardiorenal Syndrome

    Rochester, MN

  2. CLIP-IT Post Market Study: Exclusion Of The Left Atrial Appendage With Penditure™

    Rochester, MN

  3. A Study of the Effects of Decreasing the Lasix Dose on the Cardiorenal System

    Rochester, MN

  4. Evaluating The Benefit Of Concurrent Tricuspid Valve Repair During Mitral Surgery

    Rochester, MN

  5. A Study Evaluating The Effects Of Ataciguat (HMR1766) On Aortic Valve Calcification

    Rochester, MN

  6. Cardiac Resynchronization and Iodine Meta-Iodobenzylguanidine (MIBG) Imaging

    Rochester, MN

  7. Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial

    Rochester, MN

  8. A Study Comparing Apixaban To Vitamin K Antagonist For The Prevention Of Stroke Or Systemic Embolism And Bleeding In Patients With Non-valve Atrial Fibrillation And Acute Coronary Syndrome Or Percutaneous Coronary Intervention

    Scottsdale/Phoenix, AZ

  9. Evaluation Of Transcatheter Aortic Valve Replacement Compared To SurveilLance For Patients With AsYmptomatic Severe Aortic Stenosis

    Rochester, MN

  10. The Canadian CABG Or PCI In Patients With Ischemic Cardiomyopathy Trial

    Rochester, MN

.

Mayo Clinic Footer